18
Feb
2010
Acton Pharmaceuticals, Inc.: Series A $15M
Posted in I - Series A, Q - 1Q10, R - NORTH EAST, X - Asthma, X - Respiratory, XX - MA
Acton Pharmaceuticals (Marlborough, MA) a near commercial-stage pharmaceutical company focused on a HFA-propelled aerosol inhaled corticosteroid for the treatment of asthma, closed a $15M Series A financing. Participants include Sequoia Capital.
OnBioVC PARTNERS
-
